The concept of peptide bioregulation is based on the observation that short peptides composed of two to four amino acid residues can influence cell function in a tissue-specific manner. In a series of works (Khavinson 2002; Anisimov, Khavinson 2010), Vladimir Khavinson and colleagues hypothesized that these types of peptides are part of an internal regulatory system that controls gene expression in response to the functional state and age of the tissue.
Within this concept, the entire family was distinguished research peptides assigned to specific organs: pineal gland, thymus, vessels, heart, liver, bronchi, prostate – and pancreas, for which the working name has become Pancragen. Mechanistically, this school proposes that short regulatory peptides enter the cell and then interact with specific sites in the DNA strand or with proteins that regulate transcription, thereby modulating the expression of genes relevant to a given cell type.
In tissue culture models, the influence of peptides of this family on the proliferation and differentiation of cells derived from the “mother” tissue of the peptide was observed (Chalisova et al. 2015 – tissue-specific peptide effects). The tissue specificity hypothesis is one of the most distinctive – and at the same time most controversial – elements of this concept, because it requires a mechanism for tissue recognition by a very short peptide sequence. More broadly, the Khavinson family of short regulatory peptides includes several recurring research themes:
- Tissue-specific modulation of gene expression — hypothesis of the interaction of short peptides with DNA sequences and transcription factors
- Effect on cell proliferation and differentiation in tissue cultures derived from the “parent” organ of the peptide
- Cytoprotective and antioxidant effects in cell models subjected to stress (oxidative, metabolic)
- Gerontological context — peptides as hypothetical modulators of processes related to tissue aging (Khavinson 2002; Anisimov, Khavinson 2010)
- Short sequence and low molecular weight — tetra- and tripeptides, designed as fragments of larger tissue regulators
Pancragen takes the place of a peptide in this family tissue-specific for the pancreas — tools to study the concept of peptide bioregulation of the pancreatic cell, its secretory function, protection and regeneration in experimental models. The same organ-specific logic is reflected in related line bioregulators: Livagen for the liver, Cardiogen for heart tissue, Bronchogen for the bronchopulmonary epithelium and Prostamax for the prostate.
In the same line of organ bioregulators, the literature of the bioregulation school also considers Superfort (Pancramin) – A preparation with commercial status in Russia that should not be confused with a research reagent (distinction discussed below).